Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Immunovaccine launches DPX-NEO program to develop patient-specific neoepitope immunotherapies Immunovaccine has launched its DPX-NEO program to develop neoepitope immunotherapies to further expand the immuno-oncology applications for its DepoVax-based vaccines.
Drug Research > Drug Discovery & Development > News
Sirnaomics raises $10m to fund clinical development of anti-fibrosis programs Sirnaomics, a biopharmaceutical company in discovery and development of RNAi therapeutics, has closed Series B financing of $10m.
Drug Research > Drug Discovery & Development > News Ergomed to acquire Haemostatix By PBR Staff Writer
Drug development services provider Ergomed has announced the proposed acquisition of University of Leicester spin-out firm Haemostatix for about £28m.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Graybug Vision secures $44.5m funding for clinical development activities
By PBR Staff Writer
Venture-stage pharmaceutical firm Graybug Vision has secured $44.5m in funding for clinical development activities.
Drug Research > Drug Discovery & Development > News
Ablynx announces milestone in drug discovery collaboration with Novartis
Ablynx has received an undisclosed milestone payment from its collaboration with Novartis.
Drug Research > Drug Discovery & Development > News
Cumberland Pharmaceuticals unveils new program to develop Vasculan for systemic sclerosis
Cumberland Pharmaceuticals has unveiled a new program to develop Vasculan for systemic sclerosis.
Drug Research > Drug Discovery & Development > News
X-Chem achieves milestone in drug discovery collaboration with Alexion Pharmaceuticals
X-Chem has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, triggering a payment to X-Chem.
Drug Research > Drug Discovery & Development > News
Zymeworks, GSK enter second collaboration to develop bi-specific antibodies
Zymeworks has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric drug discovery platform.
Drug Research > Drug Discovery & Development > News
NewLink Genetics wins $21.6m contract option from BARDA for Ebola vaccine development
NewLink Genetics announced that the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) has exercised its $21.6m option to support continued development of the investigational rVSV-ZEBOV-GP (Ebola) vaccine candidate.
Drug Research > Drug Discovery & Development > News
hVIVO, SEEK to work together to develop vaccines against Flu and Zika infections
By PBR Staff Writer
hVIVO has unveiled a joint venture (JV) investment with the SEEK Group for the development of vaccines against influenza and mosquito-borne diseases like the Zika virus and other flaviviruses.
Drug Research > Drug Discovery & Development > News
AstraZeneca launches genomics initiative to transform drug discovery and development
By PBR Staff Writer
AstraZeneca has launched a new initiative to screen around two million genomes sequences for information that will guide in advancing drug discovery and development across its research and development platforms.
Drug Research > Drug Discovery & Development > News
Aptuit acquires Exquiron Biotech
Aptuit has acquired Exquiron Biotech to meet customer demand for fully integrated outsourced discovery services.
Drug Research > Drug Discovery & Development > News
SBP, GSK create new center for translational neuroscience
Sanford Burnham Prebys Medical Discovery Institute (SBP) and GlaxoSmithKline (GSK) have created the SBP-GSK Center for Translational Neuroscience.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests